Researchers are racing to solve one of medicine's deadliest bottlenecks: organs die within hours after removal from the body, even on ice. The shortage of viable donor organs costs thousands of lives annually. Scientists now pursue organ banks, essentially freezers of preserved human organs ready for transplant on demand.

Current preservation methods rely on cold storage and perfusion machines that pump oxygenated fluid through organs. This buys time, but not much. A heart survives roughly four to six hours outside the body. A liver lasts slightly longer. These narrow windows force transplant teams to work frantically, restricting access to rural patients and limiting which organs surgeons can use.

Several teams are experimenting with cryopreservation, where organs are cooled to near-freezing temperatures and treated with antifreeze-like compounds. The challenge lies in ice crystal formation, which damages cell structures and tissue. Researchers at MIT and other institutions are testing protocols that prevent crystallization while maintaining organ viability.

Another approach involves normothermic perfusion, keeping organs warm and functional outside the body by continuously circulating warm, oxygenated blood through them. This preserves organs in a living state and allows surgeons to assess organ quality before transplanting. Some hearts and livers have survived this way for extended periods in laboratory settings.

Biotech companies like OrganOvo and Prelabs are developing artificial organs and improved preservation technologies. Their work targets not just longer preservation windows, but functional organs engineered from patient cells, potentially eliminating rejection risks entirely.

Success here transforms transplantation from emergency surgery into planned procedures. Organs stored safely for days or weeks would let transplant teams be selective about recipient matching. It would let rural hospitals access organs previously unavailable. It could increase the donor pool by salvaging organs currently deemed too damaged or arrived too late.

The timeline remains uncertain. Most of